In line with its purpose of unlocking the power of food to enhance quality of life for everyone, today and for generations to come, Nestlé India has launched Resource Activ, a multi-benefit, high protein supplement designed to cater to the wellness needs of active millennials.
Board approves the separation of Aster’s India and GCC businesses, subject to regulatory and corporate approvals including Aster India’s shareholders’ approval. The separation plan will unlock value for the shareholders by allowing both the India and GCC businesses to adopt a market-focused strategy and
Survivors Against TB (SATB), a collective of TB survivors, experts, and advocates, has written to Shri Narendra Modi, Prime Minister, India, to address the alarming shortage of vital anti-TB drugs across different parts of the country, as the drug shortages have continued for more than
DocSmart, a leading healthcare solution is thrilled to announce its partnership with over 15000 diagnostics, 7000 pharmacies, 6000 Individual doctors, 1000 Hospitals and 1000 Ambulances to provide a comprehensive healthcare solution under one roof. In today's fast-paced world, healthcare has become a prominent concern for individuals
Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare “A nation’s culture resides in the hearts and soul of its people,” said Mahatma Gandhi, the father of the Indian nation and the world icon of peace. Nothing would resonate better with the millions of
The Company offers end-to-end healthcare services Leading healthcare providers and renowned doctors across the world are on board Patients can consult with global healthcare experts empanelled on the platform anytime via Drs.OnCalls app Drs.OnCalls, a leading telemedicine platform based in the United States, has announced
Records revenue growth of 22% to INR 762 crores in Q4 FY23 & grew 30% to INR 3149 crores in FY23 & operating EBITDA increased by 21% to INR 181 crores in Q4 FY23 A year of market-beating growth, superior performance & an optimistic outlook towards
FY23 revenue from operations up 16% YoY to Rs. 11,933 Crs FY23 EBITDA at Rs. 1,565 Crs. and PAT (Post NCI) at 425 Crs. Q4 FY23 revenue from operations up 20% YoY to Rs. 3,262 Crs Q4 FY23 EBITDA at Rs. 506 Crs. and PAT (Post NCI) at
Entailing an initial investment of around Rs. 140 crores, the hospital will be situated in the Kasaragod district of Kerala Aster aims for the hospital to begin its operations in 2024-25 With an aim to increase its focus and growth in India, Aster DM Healthcare,
